* Fitch: Pfizer’s scrapped split decision won’t affect
ratings
Source text for Eikon:
Further company coverage:
The post BRIEF-Fitch says Pfizer’s scrapped split decision will not affect ratings appeared first on NASDAQ.
BRIEF-Fitch says Pfizer’s scrapped split decision will not affect ratings
